2 citations · 2 across the 1 of their papers we have counts for
1 paper
Alexander Partin, Thomas Brettin, Yitan Zhu +7
Patient-derived xenografts (PDXs) are an appealing platform for preclinical drug studies because the in vivo environment of PDXs helps preserve tumor heterogeneity and usually bett…